105 related articles for article (PubMed ID: 9018876)
1. Engineering novel antibody molecules.
Sensel MG; Coloma MJ; Harvill ET; Shin SU; Smith RI; Morrison SL
Chem Immunol; 1997; 65():129-58. PubMed ID: 9018876
[No Abstract] [Full Text] [Related]
2. Antibody production without animals.
Stadler BM
Dev Biol Stand; 1999; 101():45-8. PubMed ID: 10566774
[TBL] [Abstract][Full Text] [Related]
3. Insect cell culture engineering.
Bioprocess Technol; 1993; 17():1-240. PubMed ID: 7763503
[No Abstract] [Full Text] [Related]
4. Mammalian cell expression.
Gorman CM
Curr Opin Biotechnol; 1990 Oct; 1(1):36-47. PubMed ID: 1367916
[No Abstract] [Full Text] [Related]
5. Overview of vector design for mammalian gene expression.
Kaufman RJ
Methods Mol Biol; 1997; 62():287-300. PubMed ID: 9108528
[No Abstract] [Full Text] [Related]
6. [Possibilities of gene-technological production of drugs, especially also the interferons].
Hochuli E
Praxis (Bern 1994); 1995 Jan; 84(2):43-6. PubMed ID: 7839046
[TBL] [Abstract][Full Text] [Related]
7. Designing expression plasmid vectors in E. coli.
Balbás P
Methods Mol Biol; 1997; 62():11-6. PubMed ID: 9108508
[No Abstract] [Full Text] [Related]
8. Response to Ivarie: Competitive bioreactor hens on the horizon.
Etches RJ
Trends Biotechnol; 2006 Mar; 24(3):101-2. PubMed ID: 16448712
[No Abstract] [Full Text] [Related]
9. [Engineering antibody: from laboratory to clinic].
Xiao C; Zhu X
Sheng Li Ke Xue Jin Zhan; 1997 Oct; 28(4):341-4. PubMed ID: 11038688
[No Abstract] [Full Text] [Related]
10. Design of bacterial hosts for lac-based expression vectors.
Schweizer HP; Karkhoff-Schweizer RR
Methods Mol Biol; 1997; 62():17-27. PubMed ID: 9108509
[No Abstract] [Full Text] [Related]
11. Monitoring horizontal gene transfer.
Davison J
Nat Biotechnol; 2004 Nov; 22(11):1349; author reply 1349-50. PubMed ID: 15529149
[No Abstract] [Full Text] [Related]
12. Strategies for analysing and improving the expression and quality of recombinant proteins made in mammalian cells.
Jenkins N; Meleady P; Tyther R; Murphy L
Biotechnol Appl Biochem; 2009 May; 53(Pt 2):73-83. PubMed ID: 19397493
[TBL] [Abstract][Full Text] [Related]
13. Competitive bioreactor hens on the horizon.
Ivarie R
Trends Biotechnol; 2006 Mar; 24(3):99-101. PubMed ID: 16445998
[TBL] [Abstract][Full Text] [Related]
14. Antibody production and engineering in plants.
Ma JK; Hein MB
Ann N Y Acad Sci; 1996 May; 792():72-81. PubMed ID: 8678422
[TBL] [Abstract][Full Text] [Related]
15. Construction of engineered CHO strains for high-level production of recombinant proteins.
Kito M; Itami S; Fukano Y; Yamana K; Shibui T
Appl Microbiol Biotechnol; 2002 Dec; 60(4):442-8. PubMed ID: 12466885
[TBL] [Abstract][Full Text] [Related]
16. Gene activation and EPO.
Davidson S
Nat Biotechnol; 1997 Jun; 15(6):497. PubMed ID: 9181561
[No Abstract] [Full Text] [Related]
17. Engineering allergens.
Mutschlechner S; Ferreira F
Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):226-9. PubMed ID: 17124778
[No Abstract] [Full Text] [Related]
18. [The production of HIV recombinant proteins and their immunochemical characteristics].
Martynenko DL; Serhieieva TA; Chumak RM; Ivans'ka NV; Zavelevych MP
Mikrobiol Z; 1996; 58(6):67-70. PubMed ID: 9064074
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of three peptide-linked beta2-microglobulin molecules in Escherichia coli with an isocaudamer technique.
Meng F; Shen C; He Y; Miao F; Zhang J
Biotechnol Lett; 2009 Jun; 31(6):831-6. PubMed ID: 19229479
[TBL] [Abstract][Full Text] [Related]
20. Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells.
Kwaks TH; Otte AP
Trends Biotechnol; 2006 Mar; 24(3):137-42. PubMed ID: 16460822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
